Table 1.
Details of participants with histological subtype, WHO grade and spectra taken
| BTNW code |
Age (years) |
Sex | Histology | WHO grade/primary site of origin of metastatic tumour |
ATR-FTIR spectroscopy (number of spectra) |
Raman spectroscopy (number of spectra) |
|---|---|---|---|---|---|---|
| 3 | 24 | F | Glioblastoma multiforme | Grade 4 | 20 | 50 |
| 4 | 63 | M | Glioblastoma multiforme | Grade 4 | 20 | 50 |
| 5 | 47 | F | Glioblastoma multiforme | Grade 4 | 20 | 50 |
| 12 | 64 | M | Glioblastoma multiforme | Grade 4 | 20 | 50 |
| 2 | 68 | F | Glioblastoma multiforme | Grade 4 | 20 | 50 |
| 38 | 48 | M | Anaplastic astrocytoma | Grade 3 | 20 | 50 |
| 173 | 50 | M | Anaplastic astrocytoma | Grade 3 | 20 | 50 |
| 458 | 71 | F | Anaplastic astrocytoma | Grade 3 | 20 | 50 |
| 515 | 65 | M | Anaplastic astrocytoma | Grade 3 | 20 | 50 |
| 126 | 66 | M | Anaplastic astrocytoma | Grade 3 | 20 | 50 |
| 20 | 26 | M | Low-grade astrocytoma | Grade 2 | 20 | 50 |
| 203 | 42 | F | Low-grade astrocytoma | Grade 2 | 20 | 50 |
| 365 | 42 | F | Low-grade astrocytoma | Grade 2 | 20 | 50 |
| 422 | 25 | M | Low-grade astrocytoma | Grade 2 | 20 | 50 |
| 680 | 59 | M | Low-grade astrocytoma | Grade 2 | 20 | 50 |
| 1 | 39 | F | Meningioma | Grade 1 | 20 | 50 |
| 36 | 59 | M | Meningioma | Grade 1 | 20 | 50 |
| 84 | 57 | M | Meningioma | Grade 1 | 20 | 50 |
| 88 | 57 | F | Meningioma | Grade 1 | 20 | 50 |
| 91 | 56 | F | Meningioma | Grade 1 | 20 | 50 |
| 95 | 71 | F | Meningioma | Grade 1 | 20 | 50 |
| 99 | 55 | F | Meningioma | Grade 1 | 20 | 50 |
| 139 | 56 | F | Meningioma | Grade 1 | 20 | 50 |
| 143 | 65 | F | Meningioma | Grade 2 | 20 | 50 |
| 145 | 31 | F | Meningioma | Grade 1 | 20 | 50 |
| 148 | 73 | F | Meningioma | Grade 1 | 20 | 50 |
| 151 | 47 | M | Meningioma | Grade 1 | 20 | 50 |
| 262 | 75 | F | Meningioma | Grade 1 | 20 | 50 |
| 291 | 52 | F | Meningioma | Grade 1 | 20 | 50 |
| 297 | 80 | M | Meningioma | Grade 2 | 20 | 50 |
| 34 | 83 | F | Metastasis | Unknown primary site | 20 | 50 |
| 78 | 52 | F | Metastasis | Non-small cell lung cancer | 20 | 50 |
| 137 | 63 | M | Metastasis | Colon cancer | 20 | 50 |
| 164 | 54 | M | Metastasis | Oesophageal cancer | 20 | 50 |
| 181 | 79 | F | Metastasis | Unknown primary site | 20 | 50 |
| 182 | 70 | F | Metastasis | Non-small cell lung cancer | 20 | 50 |
| 215 | 34 | M | Metastasis | Lung cancer | 20 | 50 |
| 253 | 64 | F | Metastasis | Ovarian/breast cancer | 20 | 50 |
| 295 | 72 | F | Metastasis | Non-small cell lung cancer | 20 | 50 |
| 313 | 58 | M | Metastasis | Squamous cell carcinoma | 20 | 50 |
| 379 | 72 | M | Metastasis | Unknown primary site | 20 | 50 |
| 409 | 84 | F | Metastasis | Bowel cancer | 20 | 50 |
| 119 | 44 | F | Metastasis | Breast cancer | 20 | 50 |
| 271 | 81 | F | Metastasis | Previous squamous cell carcinoma | 20 | 50 |
| 274 | 67 | M | Metastasis | Colon cancer | 20 | 50 |
| 7 | 66 | M | Normal brain | N/A | 20 | 50 |
| 83 | 58 | M | Normal brain | N/A | 20 | 50 |
| 132 | 64 | F | Normal brain | N/A | 20 | 50 |
| 136 | 51 | F | Normal brain | N/A | 20 | 50 |
| 625 | 51 | F | Normal brain | N/A | 20 | 50 |
| 678 | 48 | F | Normal brain | N/A | 20 | 50 |
| 713 | 39 | F | Normal brain | N/A | 20 | 50 |
| Total | 52 (45 tumours, 7 normal) | 1040 | 2600 |